Direct comparison
Tirzepatid vs Mazdutid
How Tirzepatid and Mazdutid compare on mechanism, evidence and legal status — factual, no recommendations.
| Tirzepatid | Mazdutid | |
|---|---|---|
| Class | GLP-1 analog | GLP-1 analog |
| Evidence level | clinically established | early clinical studies |
| Legal status (DE) | prescription-only | not approved |
| WADA-listed | No | No |
| Molar mass | 4813.45 Da | 4476 Da |
| Studies cited | 3 | 2 |
| Research areas | Metabolism | Metabolism |
Tirzepatid
Tirzepatide is a dual agonist at GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors.
Full Tirzepatid profileMazdutid
Mazdutide is a dual agonist at GLP-1 and glucagon receptors, derived from oxyntomodulin (OXM).
Full Mazdutid profileImportant notice
This site is intended solely for factual, scientifically oriented information about peptides. It does not constitute medical advice, does not replace a consultation with a doctor and contains no recommendations for use in humans.
This site does not sell any substances and names no sources for unapproved substances. For medical questions, please consult qualified medical professionals.